Earnings above expectations for Abbott, sales up
The U.S. Abbott Laboratories has reported quarterly earnings slightly better than expected, driven by strong growth in sales of prescription drugs, medical devices and nutritional products.
Net income for the second quarter was virtually unchanged at 1.29 billion dollars (one billion euros), or 83 cents per share.
Excluding items, earnings in the quarter rose 13.5% to $ 1.01 per share. Analysts on average expected $ 1.00 according to Thomson Reuters consensus I / B / E / S.
Worldwide sales increased 17.8% to 8.82 billion dollars, a result consistent with the consensus that almost amounted to 8.84 billion dollars.
- The Home Depot's quarterly profit above expectations
- AMR announces its first profitable quarter in three years
- The turnover of Maurel & Prom up 80% in 2010
- Sales above expectations for Safran
- Bourbon intends to take advantage of rising oil prices
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.